Sort   by:  
 Page size 
UnknownAdjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection.
Not available
S-EPMC4748913 | biostudies-literature
UnknownCellular repressor inhibits human cytomegalovirus transcription from the UL127 promoter.
Not available
S-EPMC400324 | biostudies-literature
UnknownA strong negative transcriptional regulatory region between the human cytomegalovirus UL127 gene and the major immediate-early enhancer.
Not available
S-EPMC112936 | biostudies-literature
UnknownAccumulation Rate, Depuration Kinetics, and Tissue Distribution of Polychlorinated Dibenzo-p-Dioxins and Dibenzofurans (PCDD/Fs) in Suckler Ewes (Ovis aries).
Not available
S-EPMC11228998 | biostudies-literature
UnknownPhase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy.
Not available
S-EPMC2724854 | biostudies-literature
ProteomicsA sequence-specific RNA acetylation catalyst
N4-acetylcytidine (ac4C) is a ubiquitous RNA modification incorporated by cytidine acetyltransferase enzymes. Here, we report the biochemical characterization of Thermococcus kodakarensis Nat10 (TkNat10), an RNA acetyltransferase involved in archaeal thermotolerance. We demonstrate that TkNat10's ca...
ORGANISM(S): Mus Musculus (ncbitaxon:10090) 
2024-10-14 | MSV000096084 | MassIVE
UnknownShort and long-term prognosis of admission hyperglycemia in patients with and without diabetes after acute myocardial infarction: a retrospective cohort study.
Not available
S-EPMC9229884 | biostudies-literature
UnknownMolecular phylogeny and taxonomic revision of the sportive lemurs (Lepilemur, Primates).
Not available
S-EPMC1397877 | biostudies-literature
ProteomicsBaseline serum anti-glycan antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Validation IgM 1:50]
Purpose: There is evidence that therapeutic cancer vaccines can lengthen survival for some cancer patients, but responses vary widely from one person to another. Methods to predict clinical outcomes will advance the field and provide new insights into critical determinants of in vivo efficacy. Thi...
ORGANISM(S): Homo sapiens 
2013-04-01 | E-GEOD-42175 | biostudies-arrayexpress
ProteomicsBaseline serum anti-glycan antibodies of 28 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine [Training IgM 1:50]
Purpose: There is evidence that therapeutic cancer vaccines can lengthen survival for some cancer patients, but responses vary widely from one person to another. Methods to predict clinical outcomes will advance the field and provide new insights into critical determinants of in vivo efficacy. Thi...
ORGANISM(S): Homo sapiens 
2013-04-01 | E-GEOD-42020 | biostudies-arrayexpress
Sort   by:  
 Page size